Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease. [electronic resource]
- Clinical advances in hematology & oncology : H&O Jul 2003
- 413-5; discussion 416 p. digital
Publication Type: Case Reports; Journal Article
1543-0790
Adult Antimetabolites, Antineoplastic--therapeutic use Combined Modality Therapy Deoxycytidine--analogs & derivatives Hodgkin Disease--drug therapy Humans Male Treatment Outcome Gemcitabine